Cargando…

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine

Please cite this paper as: Svindland et al. (2012) A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses 10.1111/irv.12056000(000), 000–000. Background Highly pathogenic avian influenza A/H5N1 virus remains a potential p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svindland, Signe C., Pedersen, Gabriel K., Pathirana, Rishi D., Bredholt, Geir, Nøstbakken, Jane K., Jul‐Larsen, Åsne, Guzmán, Carlos A., Montomoli, Emanuele, Lapini, Giulia, Piccirella, Simona, Jabbal‐Gill, Inderjit, Hinchcliffe, Michael, Cox, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Part 3
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634239/ https://www.ncbi.nlm.nih.gov/pubmed/23170900 http://dx.doi.org/10.1111/irv.12056

Ejemplares similares

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF‐10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses
por: Kimoto, Takashi, et al.
Publicado: (2013)

The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001–2009
por: Vuong, Cuong D., et al.
Publicado: (2012)

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains
por: Lartey, Sarah, et al.
Publicado: (2015)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
por: Budimir, Natalija, et al.
Publicado: (2013)

Effect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low‐pathogenic avian H5N2 influenza virus
por: Forrest, Heather L., et al.
Publicado: (2013)

Inactivated influenza virus vaccine is efficient and reduces IL‐4 and IL‐6 in allergic asthma mice
por: Jian, You‐Ru, et al.
Publicado: (2013)

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats
por: Kamphuis, Tobias, et al.
Publicado: (2013)

Seasonal influenza vaccine effectiveness among children, 2010–2012
por: Fu, Chuanxi, et al.
Publicado: (2013)

Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study
por: Sheldon, Eric A., et al.
Publicado: (2012)

A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort
por: Kersun, Leslie S., et al.
Publicado: (2012)

Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care‐based cohort study
por: Kafatos, George, et al.
Publicado: (2013)

Strategic communication as planned behavior for science and risk communication: A theory‐based approach to studying communicator choice
por: Besley, John C., et al.
Publicado: (2022)

Are you prepared for the next storm? Developing social norms messages to motivate community members to perform disaster risk mitigation behaviors
por: Lim, JungKyu Rhys, et al.
Publicado: (2022)

Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
por: Pedersen, Gabriel Kristian, et al.
Publicado: (2011)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils
por: Mohn, Kristin Greve-Isdahl, et al.
Publicado: (2016)

Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study
por: Trieu, Mai-Chi, et al.
Publicado: (2019)

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants
por: Jul-Larsen, Åsne, et al.
Publicado: (2012)

Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9‐year period
por: Lunelli, Antonella, et al.
Publicado: (2012)

Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein
por: Jul-Larsen, Åsne, et al.
Publicado: (2010)

Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation
por: Harling, Leanne, et al.
Publicado: (2017)

Improving musculoskeletal health for children and young people – A ‘call to action’
por: Foster, Helen E., et al.
Publicado: (2020)

Telemedicine and current clinical practice trends in the COVID-19 pandemic
por: Wahezi, Sayed E., et al.
Publicado: (2021)

The protective effect of rheumatic disease agents in COVID-19
por: Valenzuela-Almada, María O., et al.
Publicado: (2021)

Reducing the risk of infection to patients and staff during gynaecological outpatient and ambulatory appointments
por: Farmer, Natalie, et al.
Publicado: (2021)

Vaccines - safety in pregnancy
por: Arora, Mala, et al.
Publicado: (2021)

Réponse vaccinale contre la Covid en transplantation pulmonaire
por: Dauriat, G., et al.
Publicado: (2022)

Trio for three flutes, op. 26 = Trio für drei Flöten /
por: Reicha, Anton, 1770-1836
Publicado: (1985)

Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response
por: Madsen, Anders, et al.
Publicado: (2021)

Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
por: Mohn, Kristin G.-I., et al.
Publicado: (2015)

Radioprotection calculations for the EURISOL-DS direct target irradiation program at PSI
por: Zanini, L
Publicado: (22/0)

Baseline parameters – 05/27/2005 Eurisol-DS task #3 “100kW direct target station”
por: Stora, T
Publicado: (23/0)

W converter - BeO dual target prototype for 6He production - a preliminary note
por: Stora, T, et al.
Publicado: (23/1)

Online tests of a high power solid Al2O3 EURISOL target prototype
por: Fernandes, S, et al.
Publicado: (24/0)

First negative halogen beams produced at PSBooster-ISOLDE
por: Stora, T, et al.
Publicado: (22/0)

Feasibility of High Power Refractory Metal-Foil Targets for EURISOL
por: Wilfinger, R, et al.
Publicado: (2007)

Optimization of 6He production using W or Ta converter surrounded by BeO target assembly
por: N. Thiollieres, J.C. David, V. Blideanu, D. Dore, B. Rapp, D. Ridikas
Publicado: (23/1)

Feasibility study for the 100kW direct targets
por: T. Stora, J. Lettry, R. Catherall, E. Noah, R. Wilfinger, L. Penescu, E. Bouquerel, S. Fernandes, M. Santana-Leitner, L. Zanini, I. Guenter, F. Groeschel
Publicado: (23/1)

Engineering aspects for the EURISOL 100kW liquid metal targets
por: E. Noah
Publicado: (10/0)

Cannot write session to /tmp/vufind_sessions/sess_a08pqmg0aaphstr3u9n98cjkvm